Profile
Leonard Bell is the founder of Alexion Pharmaceuticals, Inc. which was founded in 1992.
He held the title of Chairman from 2015 to 2017.
Dr. Bell also held former positions as Director at The Medicines Co. from 2000 to 2005, Director at Biotechnology Research & Development Corp.
from 1993 to 1997, and Assistant Professor at Yale School of Medicine.
Dr. Bell received his undergraduate degree from Brown University and his doctorate from Yale School of Medicine.
Former positions of Leonard Bell
| Companies | Position | End |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Chief Executive Officer | 01/04/2015 |
| THE MEDICINES COMPANY | Director/Board Member | 01/04/2005 |
Biotechnology Research & Development Corp.
 Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Biotechnology Research & Development Corp. provides research on animal and plant healthcare, material sciences and biotechnology. The company is headquartered in Peoria, IL. | Director/Board Member | 01/01/1997 |
| Yale School of Medicine | Corporate Officer/Principal | - |
Training of Leonard Bell
| Brown University | Undergraduate Degree |
| Yale School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Biotechnology Research & Development Corp.
Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Biotechnology Research & Development Corp. provides research on animal and plant healthcare, material sciences and biotechnology. The company is headquartered in Peoria, IL. | Commercial Services |
- Stock Market
- Insiders
- Leonard Bell
